Expert Insights Newsletter

Photo

Omega-3 and Omega-6 Fatty Acids — Measuring Blood Levels To Help Manage Cardiovascular Risk

While recommendations for dietary intake of omega-3 fatty acids to reduce cardiovascular disease risk are well established, debate continues about the benefits of omega-3 supplementation.1-4 Dr. Robert Superko, Chief Medical Officer, Celera, reviews the evidence relating to omega-3 intake and... Read more 

Photo

Vaginitis — Molecular Testing To Address Diagnostic Challenges

Vaginitis is the most common gynecologic diagnosis in the primary care setting, affecting one in three women in their lifetime, but diagnosing its cause can be challenging.1 Dr. Dale Schwab, Senior Scientific Director, Infectious Disease, Quest Diagnostics Nichols Institute and... Read more 

Photo

Rheumatoid Arthritis and Psoriatic Arthritis: The Role of Laboratory Testing in Disease Management

The diagnosis of rheumatoid arthritis (RA) and psoriatic arthritis (PsA) is primarily based on clinical criteria, but laboratory testing plays an important role in helping define the disease and manage therapy. Dr. Martin Bergman, Clinical Associate Professor of Medicine, Drexel... Read more 

Photo

Epilepsy: How Next-Generation Genetic Testing Can Direct Therapy and Enhance Patient Care

Many types of epilepsy are associated with a genetic mutation, but determining the etiology of certain epilepsies remains a challenge. Dr. Scott Perry, Medical Director, Epilepsy Monitoring Unit, Cook Children's Health Care System, discusses how advances in genetic testing, including... Read more 

Photo

BRCA Mutation Testing — Identifying Risk for Hereditary Breast and Ovarian Cancer

Compared to the general population, patients with a confirmed BRCA mutation have a significantly increased risk of developing cancer during their lifetime - up to an 85% risk of breast cancer, up to a 40% risk of ovarian cancer, and... Read more 

Photo

Developmental Delay: Genetic Testing’s Role to Help Guide Diagnosis and Treatment

Causes of developmental delay are typically identified by a combination of observation, physical examination, assessment of family history and a range of diagnostic tests. For disorders of uncertain etiology, chromosomal microarray (CMA) testing provides clinicians with an additional diagnostic tool,... Read more